F.D.A. Approves Afinitor and Kyprolis for Breast Cancer and Myeloma
Linkedin

F.D.A. Approves Afinitor and Kyprolis for Breast Cancer and Myeloma

Zurich : Switzerland | Jul 20, 2012 at 11:44 PM PDT
Source: The New York Times
XX XX
Views: Pending
 
New drugs for breast cancer and multiple myeloma won approval from the Food and Drug Administration on Friday, expanding options for patients in advanced stages of those diseases. The breast cancer drug, Afinitor from Novartis , seems to expand the time that endocrine therapy can keep the disease... FULL ARTICLE AT The New York Times
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.